Company Progenics Pharmaceuticals, Inc.
Equities
US7431871067
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 19-11-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 19-11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 86,796,000 | 85,730,040 ( 98.77 %) | 200,000 ( 0.2304 %) | 98.77 % |
Company contact information
Progenics Pharmaceuticals, Inc.
One World Trade Center 47th floor
10007-0089, New York
+
http://www.progenics.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |